1. Targeting IGF-1 signaling pathways in gynecologic malignancies
   Ilan Bruchim et al, 2013, Expert Opinion on Therapeutic Targets CrossRef
2. Hyperinsulinemia Promotes Esophageal Cancer Development in a Surgically-Induced Duodeno-Esophageal Reflux Murine Model
   Diletta Arcidiacono et al, 2018, International Journal of Molecular Sciences CrossRef
3. The IGF pathway is activated in insulinomas but downregulated in metastatic disease
   Mieke E R Henfling et al, 2018, Endocrine-Related Cancer CrossRef
4. Correlations of insulin-like growth factor I and insulin-like growth factor I receptor with the clinicopathological features and prognosis of patients with colon cancer
   Lu Han et al, 2016, Japanese Journal of Clinical Oncology CrossRef
5. Antioxidant Barrier, Redox Status, and Oxidative Damage to Biomolecules in Patients with Colorectal Cancer. Can Malondialdehyde and Catalase Be Markers of Colorectal Cancer Advancement?
   Justyna Zińczuk et al, 2019, Biomolecules CrossRef
6. Absence or low IGF‐1R‐expression in esophageal adenocarcinoma is associated with tumor invasiveness and radicality of surgical resection
   Kirstin De Bruijn et al, 2015, Journal of Surgical Oncology CrossRef
7. Specific metabolic biomarkers as risk and prognostic factors in colorectal cancer
   Małgorzata Muc-Wierzgoń, 2014, World Journal of Gastroenterology CrossRef
8. Insulin promotes HER2 signaling activation during Barrett’s Esophagus carcinogenesis
   Diletta Arcidiacono et al, 2017, Digestive and Liver Disease CrossRef
9. Strong association of insulin-like growth factor 1 receptor expression with histologic grade, subtype, and HPV status in penile squamous cell carcinomas: a tissue microarray study of 112 cases
   Sheila F. Faraj et al, 2017, Virchows Archiv CrossRef